DR. STEVEN L TEITELBAUM, MD
Medical Practice at Kingshighway Blvd, Saint Louis, MO
License number
Missouri 29658
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
216 S Kingshighway Blvd, Saint Louis, MO 63110
Phone
(314) 362-5641
(314) 362-0369 (Fax)
(314) 362-0369 (Fax)
Personal information
See more information about STEVEN L TEITELBAUM at radaris.comName
Address
Phone
4909 Laclede Ave APT 1401, Saint Louis, MO 63108
4909 Laclede Ave #1401, Saint Louis, MO 63108
536 Overhill Dr, Saint Louis, MO 63130
Professional information
Steven L Teitelbaum, Saint Louis MO
Specialties:
Pathology, Anatomic Pathology & Clinical Pathology, Anatomic Pathology, Clinical Pathology
Work:
Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110 Washington University at St. Louis
216 S Kingshighway Blvd, Saint Louis, MO 63110
660 S Euclid Ave, Saint Louis, MO 63110 Washington University at St. Louis
216 S Kingshighway Blvd, Saint Louis, MO 63110
Education:
Washington University at St. Louis (1964)
Dr. Steven L Teitelbaum, Saint Louis MO - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
BJC Pathology & Immunology
660 S Euclid Ave SUITE 8118, Saint Louis 63110
(314) 362-0101 (Phone)
660 S Euclid Ave SUITE 8118, Saint Louis 63110
(314) 362-0101 (Phone)
Certifications:
Anatomic & Clinical Pathology, 1970
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
BJC Pathology & Immunology
660 S Euclid Ave SUITE 8118, Saint Louis 63110
Barnes Jewish Hospital
1 Barnes Jewish Hospital Plz, Saint Louis 63110
660 S Euclid Ave SUITE 8118, Saint Louis 63110
Barnes Jewish Hospital
1 Barnes Jewish Hospital Plz, Saint Louis 63110
Education:
Medical School
Washington Center / School of Medicine
Graduated: 1964
Barnes-Jewish Hospital
Bellevue Hospital Center
Washington Center / School of Medicine
Graduated: 1964
Barnes-Jewish Hospital
Bellevue Hospital Center
Stimulation Of Osteogenesis Using Rank Ligand Fusion Proteins
US Patent:
2003001, Jan 16, 2003
Filed:
Mar 22, 2002
Appl. No.:
10/105057
Inventors:
Jonathan Lam - West Memphis AR, US
F. Ross - Olivette MO, US
Steven Teitelbaum - University City MO, US
F. Ross - Olivette MO, US
Steven Teitelbaum - University City MO, US
Assignee:
Barnes-Jewish Hospital
International Classification:
A61K038/17
US Classification:
514/012000
Abstract:
A method of enhancing bone formation comprising administering an effective amount of 1) an oligomeric complex of one or more of RANKL, a RANKL fusion protein or an analog, derivative or mimic thereof, 2) an osteogenic compound capable of enhancing activity of one or more intracellular proteins in osteoblasts or osteoblast precursors, wherein said activity is indicative of bone formation, or 3) an osteogenic compound capable of inactivating one or more phosphatases in osteoblasts or osteoblast precursors, wherein said inactivation is indicative of bone formation. The method also may be used to treat a disease or condition manifested at least in part by the loss of bone mass by administering to a patient a pharmaceutical composition comprising an oligomeric complex or osteogenic compound disclosed herein.
Inhibitors Of Cell-Mediated Disorders
US Patent:
5821265, Oct 13, 1998
Filed:
Jun 11, 1997
Appl. No.:
8/872901
Inventors:
Paul H. Schlesinger - University City MO
Steven L. Teitelbaum - University City MO
Harry C. Blair - Mountain Brook AL
Steven L. Teitelbaum - University City MO
Harry C. Blair - Mountain Brook AL
Assignee:
Barnes-Jewish Hospital - St. Louis MO
International Classification:
A61K 31555
US Classification:
514492
Abstract:
The present invention provides a method for blocking a cellular proton pump that comprises contacting a cell with a cellular proton pump-blocking effective quantity of In-EDTA or Tl-EDTA. The present invention also provides a method of treating or preventing cell-mediated disorders in a vertebrate animal by administering In-EDTA or Tl-EDTA to the vertebrate animal, as well as a method for stopping the cellular proton pump-blocking effect of Group IIIa metals such as Ga, In, and Tl, through use of suitable chelating agents. Suitable compositions for use in the aforementioned methods are provided as well.
Inhibitors Of Cell-Medicated Disorders
US Patent:
5763480, Jun 9, 1998
Filed:
Feb 14, 1994
Appl. No.:
8/196293
Inventors:
Paul H. Schlesinger - University City MO
Steven L. Teitelbaum - University City MO
Harry C. Blair - Mountain Brook AL
Steven L. Teitelbaum - University City MO
Harry C. Blair - Mountain Brook AL
Assignee:
The Jewish Hospital of St. Louis - St. Louis MO
International Classification:
A61K 3128
US Classification:
514476
Abstract:
The present invention provides a method for blocking a cellular proton pump that comprises contacting a cell with a cellular proton pump-blocking effective quantity of In-EDTA or Tl-EDTA. The present invention also provides a method of treating or preventing cell-mediated disorders in a vertebrate animal by administering In-EDTA or Tl-EDTA to the vertebrate animal, as well as a method for stopping the cellular proton pump-blocking effect of Group IIIa metals such as Ga, In, and Tl, through use of suitable chelating agents. Suitable compositions for use in the aforementioned methods are provided as well.